Glaucoma
“Preservative Toxicity a Disease,” Reports Working Group on Glaucoma Medication Preservatives Toxicity
Valeant Ophthalmics, a division of Valeant Pharmaceuticals North America LLC, announced that the Working Group on Preservatives Toxicity in Glaucoma Medications, an advisory panel of glaucoma treatment experts, was recently convened as an ongoing group to examine the issue of preservatives in glaucoma medications from an evidence-based perspective. The Working Group is sponsored by Valeant Ophthalmics. At its first roundtable, the Working Group discussed the interface between ocular surface dise...
Bevacizumab Prevents Posttrabeculectomy Complications
The antiangiogenesis agent bevacizumab had an 80% success rate in the maintenance of postoperative improvement in intraocular pressure (IOP) after trabeculectomy. In addition, the drug reduced the incidence of subconjunctival scarring, according to findings presented here at the World Ophthalmology Congress (WOC) 2012.
Intake of Calcium, Iron Supplement Associated With Glaucoma
Supplementary consumption of the oxidants calcium and iron may be a risk factor for the development of glaucomatous disease, according to a study in Investigative Ophthalmology and Visual Science. The investigators reviewed the 2007 to 2008 National Health and Nutrition Examination Survey to assess the relationship between self-reported glaucoma and the supplementary consumption of calcium and iron.
Outside temperatures, sun exposure and gender may trigger glaucoma
When it comes to whether or not you will develop exfoliation syndrome -- an eye condition that is a leading cause of secondary open-angle glaucoma and increased risk of cataract as well as cataract surgery complications -- age, gender and where you live does matter.
Two-At-Once Visual Field Testing: More Efficient, Equally Accurate
Ophthalmology practices could save time and money by performing visual field (VF) testing on more than one patient at a time, say researchers at the University of Michigan. Their study, published online November 23 in Ophthalmology, found no decrease in VF testing performance or reliability when two patients are tested simultaneously in the same room, by one technician.
Ivantis Announces Results of Hydrus Implant Study
Last week, Ivantis announced the 6-month results from its multi-center, international Hydrus I study at the European Society of Cataract and Refractive Surgery Meeting (ESCRS).
The Hydrus(TM) Intracanalicular Implant, roughly the size of an eyelash, is placed through a minimally invasive, microsurgical procedure and is designed to reduce eye pressure by reestablishing the patient’s conventional outflow pathway. The Hydrus device relies on a twofo (Read more...)
Canaloplasty an Option in Open-Angle Glaucoma
Canaloplasty works just as well as trabeculectomy in reducing intraocular pressure (IOP) in patients with open-angle glaucoma, according to a comparative case series in Ophthalmology.
Acucela and Otsuka Pharmaceutical Announce the Initiation of a Phase 1/2 Clinical Trial for OPA-6566 in Patients with Open-angle Glaucoma or Ocular Hypertension
SEATTLE & TOKYO--(BUSINESS WIRE)--Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced the initiation of a Phase 1/2 clinical trial for OPA-6566. OPA-6566, an adenosine A2a receptor agonist, is being developed as an ophthalmic solution to reduce intraocular pressure in open-angle glaucoma (OAG) or ocular hypertension patients. OPA-6566 was discovered by Otsuka. The compound offers
Transcend Medical Closes $51M Series B Financing
Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, announced the closure of its second tranche, bringing the total of Series B to $51M.
Oxidative Metabolism in the Eye Differs According to Race
Greater oxygen levels among people of African descent may help explain their higher risk for glaucoma.
Medscape Medical News
Medscape Medical News
The Role of Surgical Intervention in Reducing Costs
Several years ago, when a senior
official at the FDA was asked why
there was such a difference in getting
licensing for glaucoma medicines
compared to glaucoma devices, the
answer, slightly in jest, was, “The device
has only got to show it...
The Literature
h4SHORT-TERM REPEATABILITY OF DIURNAL
INTRAOCULAR PRESSURE PATTERNS IN
GLAUCOMATOUS INDIVIDUALSsup1/sup/h4
emRealini T, Weinreb N, Wisniewski S.*br /
Ophthalmology/em, January 2011
strongDo patients treated for primary ...
CHIEF MEDICAL EDITOR’S PAGE: Carpe Diem
Economic discussions have dominated the
national conversation of the past few years.
The current health care system appears to
be unsustainable. Medicare A is projected
to go bankrupt in 2019, health insurance premiums
have doubled since 2001...
Why Do I Perform Research?
When my 2 1/2-year-old son asks, “Why are
trees green? Why did Mama sneeze? Why
did baby Alex spit up?” I smile. I smile
because I am amazed at how inquisitive
human beings are, even at such a young age. I smile
because others once had th...
Marketing Methodologies for High-Growth Practices
As you are passing between your clinic’s examination
rooms on a tiring Thursday evening—your
back still sore from the previous afternoon’s surgeries—
your assistant grabs your shoulder to
alert you that tonight is the deadline to renew...
The Zhongshan Angle Closure Prevention Trial
By the year 2020, primary angleclosure
glaucoma (PACG) will
account for half of the 11 million
people who are estimated to be
bilaterally blind from glaucoma.sup1/sup China is
home to the majority of people with
PACG worldwide. An estima...
Maximizing the Benefits of Topical Therapy
The options for the topical medical therapy of
glaucoma have greatly increased during the past
3 decades. The introduction of new classes of
medication, often with several choices within a
class, lower IOP more effectively than ever before. Th...
Word From the Cutting Edge
Early in March 2011, emGlaucoma Today/em held the
third annual Cutting Edge: Innovative Glaucoma
Surgery Symposium. Iqbal Ike Ahmed, MD, and
Richard Lewis, MD, served as the course directors
of this 1-day event that brought together clinic...
Optimizing Glaucoma Practice Models
h3After the Accountable
Care Act, physicians face
a new world./h3
strongBy William L. Rich III, MD/strongbr /
The passage of the Patient Protection and
Accountable Care Act (ACA) in 2010 marked
the culmination of the US government...
Highlights of the AGS Annual Meeting
Every year, the AGS meeting features presentations of
the best in glaucoma research. This year, more than
600 registrants enjoyed 68 poster and 24 paper presentations
as well as a glaucoma surgery day, several
symposia, roundtables, workshops,...
Subscribe
